551 related articles for article (PubMed ID: 18533229)
1. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
Sterrett SP; Penniston KL; Wolf JS; Nakada SY
Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
[TBL] [Abstract][Full Text] [Related]
2. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
[TBL] [Abstract][Full Text] [Related]
3. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
4. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
Penniston KL; Steele TH; Nakada SY
Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
[TBL] [Abstract][Full Text] [Related]
5. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
[TBL] [Abstract][Full Text] [Related]
6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
7. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
Trinchieri A; Esposito N; Castelnuovo C
Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
[TBL] [Abstract][Full Text] [Related]
8. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
9. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
Whitson PA; Pietrzyk RA; Jones JA; Nelman-Gonzalez M; Hudson EK; Sams CF
J Urol; 2009 Nov; 182(5):2490-6. PubMed ID: 19765769
[TBL] [Abstract][Full Text] [Related]
10. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
12. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
Jiménez Verdejo A; Arrabal Martín M; Miján Ortiz JL; Hita Rosino E; Palao Yago F; Zuluaga Gómez A
Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
[TBL] [Abstract][Full Text] [Related]
13. Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation.
Whitson JM; Cooperberg MR; Stackhouse GB; Stoller ML
Urology; 2007 Oct; 70(4):634-7. PubMed ID: 17991528
[TBL] [Abstract][Full Text] [Related]
14. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
Pak CY; Peterson RD; Poindexter J
J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
[TBL] [Abstract][Full Text] [Related]
15. [Preventive measures in stones due to infection, uric acid and cystine].
Hess B; Ackermann D
Ther Umsch; 1992 Jan; 49(1):44-8. PubMed ID: 1736401
[TBL] [Abstract][Full Text] [Related]
16. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
17. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
18. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
Dhar NB; Grundfest S; Jones JS; Streem SB
J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
[TBL] [Abstract][Full Text] [Related]
19. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
Worcester EM; Coe FL; Evan AP; Parks JH
BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
[TBL] [Abstract][Full Text] [Related]
20. Stone clustering of patients with cystine urinary stone formation.
Purohit RS; Stoller ML
Urology; 2004 Apr; 63(4):630-4; discussion 634-5. PubMed ID: 15072865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
